B
VNDA icon

Bailard’s Vanda Pharmaceuticals VNDA Stock Holding History

Bailard’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Buy
+16,800
New +$130K ﹤0.01% 719
2025
Q4 		– Sell
-26,169
Closed -$131K – 885
2025
Q3 		$131K Buy
26,169
+69
+0.3% +$319 ﹤0.01% 752
2025
Q2 		$123K Buy
26,100
+3,631
+16% +$15.9K ﹤0.01% 735
2025
Q1 		$103K Buy
+22,469
New +$105K ﹤0.01% 718
2024
Q1 		– Sell
-26,300
Closed -$111K – 824
2023
Q4 		$111K Buy
+26,300
New +$106K ﹤0.01% 684

Other funds holding VNDA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return